Tinavi Medical Technologies Stock Fundamentals

688277 Stock   10.66  0.08  0.74%   
Tinavi Medical Technologies fundamentals help investors to digest information that contributes to Tinavi Medical's financial success or failures. It also enables traders to predict the movement of Tinavi Stock. The fundamental analysis module provides a way to measure Tinavi Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tinavi Medical stock.
At present, Tinavi Medical's Tax Provision is projected to decrease significantly based on the last few years of reporting. The current year's Interest Expense is expected to grow to about 6.7 M, whereas Net Interest Income is projected to grow to (3.5 M).
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Tinavi Medical Technologies Company Current Valuation Analysis

Tinavi Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Tinavi Medical Current Valuation

    
  4.83 B  
Most of Tinavi Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tinavi Medical Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Tinavi Medical Technologies has a Current Valuation of 4.83 B. This is 66.36% lower than that of the Health Care Equipment & Supplies sector and 47.15% lower than that of the Health Care industry. The current valuation for all China stocks is 70.93% higher than that of the company.

Tinavi Medical Techn Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Tinavi Medical's current stock value. Our valuation model uses many indicators to compare Tinavi Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tinavi Medical competition to find correlations between indicators driving Tinavi Medical's intrinsic value. More Info.
Tinavi Medical Technologies is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Tinavi Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Tinavi Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Tinavi Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tinavi Medical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tinavi Medical could also be used in its relative valuation, which is a method of valuing Tinavi Medical by comparing valuation metrics of similar companies.
Tinavi Medical is currently under evaluation in current valuation category among its peers.

Tinavi Fundamentals

About Tinavi Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Tinavi Medical Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tinavi Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tinavi Medical Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Total Revenue210 M170.9 M
Cost Of Revenue60.6 M44.7 M

Currently Active Assets on Macroaxis

Other Information on Investing in Tinavi Stock

Tinavi Medical financial ratios help investors to determine whether Tinavi Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tinavi with respect to the benefits of owning Tinavi Medical security.